Johansen NJ, Dejgaard TF, Lund A, Schluntz C, et al. Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial. Diabetes Obes Metab 2020 Jun 16. doi: 10.1111/dom.14078.
PMID: 32543021